Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer
Clinical trial NCT01047891 · COMPLETED
Trial details
- NCT number
- NCT01047891
- Sponsor
- JSehouli
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2015-02-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.